Structure

Physi-Chem Properties

Molecular Weight:  348.1
Volume:  355.133
LogP:  5.534
LogD:  2.84
LogS:  -3.413
# Rotatable Bonds:  1
TPSA:  101.15
# H-Bond Aceptor:  5
# H-Bond Donor:  5
# Rings:  4
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.253
Synthetic Accessibility Score:  2.847
Fsp3:  0.048
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  2
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.279
MDCK Permeability:  8.208146937249694e-06
Pgp-inhibitor:  0.01
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.741
20% Bioavailability (F20%):  0.058
30% Bioavailability (F30%):  0.994

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.004
Plasma Protein Binding (PPB):  97.77272033691406%
Volume Distribution (VD):  0.496
Pgp-substrate:  7.7612690925598145%

ADMET: Metabolism

CYP1A2-inhibitor:  0.928
CYP1A2-substrate:  0.268
CYP2C19-inhibitor:  0.056
CYP2C19-substrate:  0.057
CYP2C9-inhibitor:  0.64
CYP2C9-substrate:  0.622
CYP2D6-inhibitor:  0.082
CYP2D6-substrate:  0.374
CYP3A4-inhibitor:  0.043
CYP3A4-substrate:  0.041

ADMET: Excretion

Clearance (CL):  5.439
Half-life (T1/2):  0.564

ADMET: Toxicity

hERG Blockers:  0.006
Human Hepatotoxicity (H-HT):  0.141
Drug-inuced Liver Injury (DILI):  0.933
AMES Toxicity:  0.751
Rat Oral Acute Toxicity:  0.14
Maximum Recommended Daily Dose:  0.894
Skin Sensitization:  0.965
Carcinogencity:  0.717
Eye Corrosion:  0.003
Eye Irritation:  0.923
Respiratory Toxicity:  0.506

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC245923

Natural Product ID:  NPC245923
Common Name*:   1,6,11-Trihydroxy-8-Propyltetracene-5,12-Dione
IUPAC Name:   1,6,11-trihydroxy-8-propyltetracene-5,12-dione
Synonyms:  
Standard InCHIKey:  YFRSOTKZPUMXIQ-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C21H16O5/c1-2-4-10-7-8-11-13(9-10)20(25)16-17(18(11)23)21(26)15-12(19(16)24)5-3-6-14(15)22/h3,5-9,22-23,25H,2,4H2,1H3
SMILES:  CCCc1ccc2c(c1)c(O)c1c(c2O)C(=O)c2c(C1=O)cccc2O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2024355
PubChem CID:   57381513
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000022] Naphthacenes
        • [CHEMONTID:0000155] Tetracenequinones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32815 micromonospora sp. Species Micromonosporaceae Bacteria n.a. n.a. n.a. PMID[22250891]
NPO32815 micromonospora sp. Species Micromonosporaceae Bacteria n.a. n.a. n.a. PMID[25375258]
NPO32815 micromonospora sp. Species Micromonosporaceae Bacteria n.a. n.a. n.a. PMID[26444379]
NPO32815 micromonospora sp. Species Micromonosporaceae Bacteria n.a. n.a. n.a. PMID[27813411]
NPO32815 micromonospora sp. Species Micromonosporaceae Bacteria n.a. n.a. n.a. PMID[31794218]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT180 Cell Line HCT-8 Homo sapiens IC50 = 12700.0 nM PMID[512857]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC245923 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9923 High Similarity NPC474813
0.9621 High Similarity NPC155211
0.9538 High Similarity NPC205992
0.9474 High Similarity NPC272268
0.9398 High Similarity NPC283088
0.9394 High Similarity NPC225051
0.9308 High Similarity NPC48248
0.9308 High Similarity NPC282923
0.9281 High Similarity NPC471683
0.9248 High Similarity NPC115458
0.9242 High Similarity NPC474517
0.9242 High Similarity NPC72669
0.9209 High Similarity NPC10764
0.9203 High Similarity NPC19631
0.9203 High Similarity NPC239136
0.9179 High Similarity NPC161964
0.9179 High Similarity NPC287604
0.9179 High Similarity NPC472262
0.9173 High Similarity NPC58685
0.9167 High Similarity NPC55949
0.9154 High Similarity NPC96915
0.9137 High Similarity NPC471682
0.9118 High Similarity NPC305060
0.9091 High Similarity NPC34414
0.9091 High Similarity NPC99731
0.9091 High Similarity NPC146647
0.9077 High Similarity NPC103540
0.9065 High Similarity NPC257644
0.9058 High Similarity NPC96421
0.9058 High Similarity NPC225243
0.9051 High Similarity NPC13715
0.903 High Similarity NPC70622
0.9008 High Similarity NPC306765
0.9 High Similarity NPC142956
0.9 High Similarity NPC173978
0.8993 High Similarity NPC246638
0.8993 High Similarity NPC124365
0.8971 High Similarity NPC80035
0.8955 High Similarity NPC244699
0.8923 High Similarity NPC375356
0.8897 High Similarity NPC50924
0.8897 High Similarity NPC288089
0.8889 High Similarity NPC242358
0.8889 High Similarity NPC246693
0.8889 High Similarity NPC110609
0.8881 High Similarity NPC136588
0.8881 High Similarity NPC37709
0.8881 High Similarity NPC199253
0.8864 High Similarity NPC3224
0.8849 High Similarity NPC138099
0.8849 High Similarity NPC143438
0.8849 High Similarity NPC242994
0.8846 High Similarity NPC300274
0.8844 High Similarity NPC66029
0.8841 High Similarity NPC62272
0.8828 High Similarity NPC315520
0.8824 High Similarity NPC314048
0.8824 High Similarity NPC53896
0.8811 High Similarity NPC147250
0.8806 High Similarity NPC278928
0.8797 High Similarity NPC471530
0.8794 High Similarity NPC69755
0.8786 High Similarity NPC169452
0.8786 High Similarity NPC315578
0.8786 High Similarity NPC181560
0.8741 High Similarity NPC31539
0.8732 High Similarity NPC296752
0.8723 High Similarity NPC187843
0.8714 High Similarity NPC1268
0.8714 High Similarity NPC26924
0.8705 High Similarity NPC471905
0.8705 High Similarity NPC53206
0.8705 High Similarity NPC53414
0.8702 High Similarity NPC307174
0.8699 High Similarity NPC205766
0.8696 High Similarity NPC161632
0.8686 High Similarity NPC52407
0.8681 High Similarity NPC300540
0.8676 High Similarity NPC85342
0.8671 High Similarity NPC227841
0.8662 High Similarity NPC474300
0.8662 High Similarity NPC193555
0.8649 High Similarity NPC218870
0.8649 High Similarity NPC474824
0.8649 High Similarity NPC470408
0.8649 High Similarity NPC182921
0.8643 High Similarity NPC416
0.8643 High Similarity NPC61398
0.8633 High Similarity NPC254847
0.8633 High Similarity NPC472308
0.8623 High Similarity NPC12070
0.8621 High Similarity NPC119767
0.8603 High Similarity NPC31799
0.8601 High Similarity NPC451542
0.8601 High Similarity NPC476473
0.8601 High Similarity NPC313047
0.8601 High Similarity NPC474203
0.8601 High Similarity NPC295712
0.8592 High Similarity NPC477275
0.8582 High Similarity NPC1991
0.8582 High Similarity NPC49647
0.8582 High Similarity NPC231774
0.8582 High Similarity NPC295202
0.8582 High Similarity NPC227741
0.8582 High Similarity NPC136342
0.8571 High Similarity NPC147418
0.8561 High Similarity NPC249272
0.8551 High Similarity NPC114183
0.854 High Similarity NPC17083
0.8533 High Similarity NPC474861
0.8531 High Similarity NPC85310
0.8531 High Similarity NPC135524
0.8531 High Similarity NPC469520
0.8511 High Similarity NPC4214
0.8507 High Similarity NPC131799
0.85 High Similarity NPC141934
0.85 High Similarity NPC191976
0.85 High Similarity NPC193358
0.8493 Intermediate Similarity NPC290194
0.8489 Intermediate Similarity NPC44437
0.8489 Intermediate Similarity NPC282780
0.8489 Intermediate Similarity NPC166480
0.8489 Intermediate Similarity NPC270899
0.8483 Intermediate Similarity NPC68441
0.8483 Intermediate Similarity NPC12402
0.8473 Intermediate Similarity NPC206778
0.8473 Intermediate Similarity NPC285829
0.8472 Intermediate Similarity NPC174905
0.8472 Intermediate Similarity NPC293545
0.8467 Intermediate Similarity NPC66508
0.8467 Intermediate Similarity NPC226656
0.8462 Intermediate Similarity NPC305845
0.8462 Intermediate Similarity NPC204045
0.8456 Intermediate Similarity NPC96024
0.8451 Intermediate Similarity NPC216312
0.8451 Intermediate Similarity NPC29771
0.8451 Intermediate Similarity NPC190457
0.8451 Intermediate Similarity NPC256463
0.8451 Intermediate Similarity NPC476477
0.8451 Intermediate Similarity NPC471602
0.8451 Intermediate Similarity NPC111422
0.8451 Intermediate Similarity NPC306835
0.8451 Intermediate Similarity NPC299405
0.8444 Intermediate Similarity NPC160499
0.844 Intermediate Similarity NPC44960
0.844 Intermediate Similarity NPC474110
0.844 Intermediate Similarity NPC53001
0.8433 Intermediate Similarity NPC68756
0.8433 Intermediate Similarity NPC152525
0.8433 Intermediate Similarity NPC310540
0.8429 Intermediate Similarity NPC258502
0.8429 Intermediate Similarity NPC22222
0.8429 Intermediate Similarity NPC281513
0.8425 Intermediate Similarity NPC314437
0.8425 Intermediate Similarity NPC285122
0.8425 Intermediate Similarity NPC271944
0.8425 Intermediate Similarity NPC110882
0.8425 Intermediate Similarity NPC85393
0.8421 Intermediate Similarity NPC324736
0.8417 Intermediate Similarity NPC267205
0.8414 Intermediate Similarity NPC244691
0.8414 Intermediate Similarity NPC193703
0.8414 Intermediate Similarity NPC471906
0.8414 Intermediate Similarity NPC21599
0.8414 Intermediate Similarity NPC79627
0.8409 Intermediate Similarity NPC472046
0.8403 Intermediate Similarity NPC474961
0.84 Intermediate Similarity NPC474622
0.84 Intermediate Similarity NPC474621
0.8397 Intermediate Similarity NPC232178
0.8394 Intermediate Similarity NPC276238
0.8392 Intermediate Similarity NPC241349
0.8392 Intermediate Similarity NPC220496
0.8392 Intermediate Similarity NPC42262
0.8392 Intermediate Similarity NPC37992
0.8392 Intermediate Similarity NPC327916
0.8392 Intermediate Similarity NPC147542
0.8392 Intermediate Similarity NPC32749
0.8389 Intermediate Similarity NPC35
0.8385 Intermediate Similarity NPC269414
0.838 Intermediate Similarity NPC87723
0.838 Intermediate Similarity NPC206207
0.8366 Intermediate Similarity NPC284495
0.8366 Intermediate Similarity NPC476506
0.8358 Intermediate Similarity NPC477153
0.8358 Intermediate Similarity NPC275145
0.8357 Intermediate Similarity NPC1249
0.8356 Intermediate Similarity NPC34482
0.8356 Intermediate Similarity NPC170055
0.8355 Intermediate Similarity NPC67197
0.8345 Intermediate Similarity NPC53016
0.8345 Intermediate Similarity NPC309430
0.8345 Intermediate Similarity NPC238629
0.8344 Intermediate Similarity NPC266469
0.8333 Intermediate Similarity NPC108129
0.8333 Intermediate Similarity NPC198305
0.8333 Intermediate Similarity NPC471444
0.8333 Intermediate Similarity NPC474534
0.8333 Intermediate Similarity NPC91019
0.8333 Intermediate Similarity NPC257003

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC245923 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9077 High Similarity NPD1470 Approved
0.8841 High Similarity NPD5408 Approved
0.8841 High Similarity NPD5405 Approved
0.8841 High Similarity NPD5406 Approved
0.8841 High Similarity NPD5404 Approved
0.8769 High Similarity NPD1201 Approved
0.8671 High Similarity NPD7390 Discontinued
0.8633 High Similarity NPD1509 Clinical (unspecified phase)
0.8483 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.8168 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.8133 Intermediate Similarity NPD3226 Approved
0.8 Intermediate Similarity NPD2346 Discontinued
0.7852 Intermediate Similarity NPD3300 Phase 2
0.7808 Intermediate Similarity NPD2935 Discontinued
0.7799 Intermediate Similarity NPD6232 Discontinued
0.7764 Intermediate Similarity NPD7473 Discontinued
0.7736 Intermediate Similarity NPD6959 Discontinued
0.7727 Intermediate Similarity NPD7635 Approved
0.7718 Intermediate Similarity NPD7003 Approved
0.7633 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7615 Intermediate Similarity NPD2342 Discontinued
0.7589 Intermediate Similarity NPD1164 Approved
0.7586 Intermediate Similarity NPD943 Approved
0.7569 Intermediate Similarity NPD3764 Approved
0.7536 Intermediate Similarity NPD3019 Approved
0.7481 Intermediate Similarity NPD5951 Approved
0.7448 Intermediate Similarity NPD2313 Discontinued
0.7442 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.744 Intermediate Similarity NPD8312 Approved
0.744 Intermediate Similarity NPD8313 Approved
0.7436 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7413 Intermediate Similarity NPD2798 Approved
0.741 Intermediate Similarity NPD2932 Approved
0.741 Intermediate Similarity NPD7163 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.74 Intermediate Similarity NPD2344 Approved
0.7383 Intermediate Similarity NPD2799 Discontinued
0.7383 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.7383 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD7768 Phase 2
0.7349 Intermediate Similarity NPD5844 Phase 1
0.731 Intermediate Similarity NPD8150 Discontinued
0.729 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.726 Intermediate Similarity NPD7008 Discontinued
0.7257 Intermediate Similarity NPD6535 Approved
0.7257 Intermediate Similarity NPD6534 Approved
0.725 Intermediate Similarity NPD7819 Suspended
0.7248 Intermediate Similarity NPD1607 Approved
0.7222 Intermediate Similarity NPD3749 Approved
0.7214 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD2309 Approved
0.7205 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD6213 Phase 3
0.72 Intermediate Similarity NPD6212 Phase 3
0.72 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.719 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD7177 Discontinued
0.7179 Intermediate Similarity NPD2534 Approved
0.7179 Intermediate Similarity NPD2533 Approved
0.7179 Intermediate Similarity NPD2532 Approved
0.717 Intermediate Similarity NPD4380 Phase 2
0.7169 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD1510 Phase 2
0.7151 Intermediate Similarity NPD6778 Approved
0.7151 Intermediate Similarity NPD6781 Approved
0.7151 Intermediate Similarity NPD6782 Approved
0.7151 Intermediate Similarity NPD6780 Approved
0.7151 Intermediate Similarity NPD6777 Approved
0.7151 Intermediate Similarity NPD6779 Approved
0.7151 Intermediate Similarity NPD6776 Approved
0.7143 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD3750 Approved
0.7143 Intermediate Similarity NPD2801 Approved
0.7135 Intermediate Similarity NPD7699 Phase 2
0.7135 Intermediate Similarity NPD7700 Phase 2
0.7125 Intermediate Similarity NPD7411 Suspended
0.7114 Intermediate Similarity NPD1240 Approved
0.7113 Intermediate Similarity NPD3023 Approved
0.7113 Intermediate Similarity NPD3026 Approved
0.7107 Intermediate Similarity NPD7458 Discontinued
0.7101 Intermediate Similarity NPD497 Approved
0.7092 Intermediate Similarity NPD3024 Approved
0.7092 Intermediate Similarity NPD3025 Approved
0.7092 Intermediate Similarity NPD1651 Approved
0.7088 Intermediate Similarity NPD7871 Phase 2
0.7088 Intermediate Similarity NPD7870 Phase 2
0.7059 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD9266 Approved
0.7037 Intermediate Similarity NPD74 Approved
0.7034 Intermediate Similarity NPD1283 Approved
0.7033 Intermediate Similarity NPD7696 Phase 3
0.7033 Intermediate Similarity NPD7435 Discontinued
0.7033 Intermediate Similarity NPD7698 Approved
0.7033 Intermediate Similarity NPD7697 Approved
0.7032 Intermediate Similarity NPD8166 Discontinued
0.703 Intermediate Similarity NPD5494 Approved
0.7029 Intermediate Similarity NPD495 Approved
0.7029 Intermediate Similarity NPD498 Approved
0.7029 Intermediate Similarity NPD496 Approved
0.7018 Intermediate Similarity NPD5029 Approved
0.7018 Intermediate Similarity NPD6559 Discontinued
0.7018 Intermediate Similarity NPD5027 Approved
0.7018 Intermediate Similarity NPD5031 Approved
0.7014 Intermediate Similarity NPD4878 Approved
0.7 Intermediate Similarity NPD9493 Approved
0.6994 Remote Similarity NPD5402 Approved
0.6978 Remote Similarity NPD6823 Phase 2
0.6975 Remote Similarity NPD6844 Discontinued
0.6963 Remote Similarity NPD9264 Approved
0.6963 Remote Similarity NPD9267 Approved
0.6963 Remote Similarity NPD9263 Approved
0.6948 Remote Similarity NPD1471 Phase 3
0.6923 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6923 Remote Similarity NPD2286 Discontinued
0.6918 Remote Similarity NPD6273 Approved
0.6913 Remote Similarity NPD4625 Phase 3
0.6913 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6903 Remote Similarity NPD970 Clinical (unspecified phase)
0.6903 Remote Similarity NPD1549 Phase 2
0.6899 Remote Similarity NPD1511 Approved
0.6894 Remote Similarity NPD289 Clinical (unspecified phase)
0.689 Remote Similarity NPD8438 Clinical (unspecified phase)
0.6883 Remote Similarity NPD1551 Phase 2
0.6882 Remote Similarity NPD7701 Phase 2
0.6879 Remote Similarity NPD5034 Approved
0.6879 Remote Similarity NPD4954 Approved
0.6879 Remote Similarity NPD36 Approved
0.6879 Remote Similarity NPD5026 Approved
0.6879 Remote Similarity NPD5028 Approved
0.6879 Remote Similarity NPD4955 Approved
0.6871 Remote Similarity NPD1934 Approved
0.6871 Remote Similarity NPD1203 Approved
0.6865 Remote Similarity NPD7211 Clinical (unspecified phase)
0.6864 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6864 Remote Similarity NPD6166 Phase 2
0.6864 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6861 Remote Similarity NPD4750 Phase 3
0.6855 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6846 Remote Similarity NPD844 Approved
0.6842 Remote Similarity NPD1932 Approved
0.6839 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6839 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6828 Remote Similarity NPD1281 Approved
0.6828 Remote Similarity NPD1611 Approved
0.6828 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6821 Remote Similarity NPD6663 Approved
0.6821 Remote Similarity NPD5030 Phase 2
0.6818 Remote Similarity NPD5038 Approved
0.6818 Remote Similarity NPD4308 Phase 3
0.6818 Remote Similarity NPD3748 Approved
0.6818 Remote Similarity NPD5037 Approved
0.6815 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6813 Remote Similarity NPD1512 Approved
0.6811 Remote Similarity NPD8320 Phase 1
0.6811 Remote Similarity NPD8319 Approved
0.6809 Remote Similarity NPD7874 Approved
0.6809 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6807 Remote Similarity NPD7075 Discontinued
0.6806 Remote Similarity NPD4626 Approved
0.6803 Remote Similarity NPD1876 Approved
0.6794 Remote Similarity NPD288 Approved
0.6791 Remote Similarity NPD1930 Approved
0.6791 Remote Similarity NPD1929 Approved
0.6791 Remote Similarity NPD1931 Clinical (unspecified phase)
0.6788 Remote Similarity NPD6831 Clinical (unspecified phase)
0.6786 Remote Similarity NPD4869 Clinical (unspecified phase)
0.6781 Remote Similarity NPD3972 Approved
0.6779 Remote Similarity NPD5736 Approved
0.6776 Remote Similarity NPD2979 Phase 3
0.6774 Remote Similarity NPD6100 Approved
0.6774 Remote Similarity NPD2796 Approved
0.6774 Remote Similarity NPD6099 Approved
0.6772 Remote Similarity NPD7801 Approved
0.6761 Remote Similarity NPD5036 Approved
0.6755 Remote Similarity NPD411 Approved
0.6755 Remote Similarity NPD8151 Discontinued
0.6752 Remote Similarity NPD2800 Approved
0.6747 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6747 Remote Similarity NPD3882 Suspended
0.6744 Remote Similarity NPD6020 Phase 2
0.6742 Remote Similarity NPD6836 Approved
0.6738 Remote Similarity NPD9281 Approved
0.6732 Remote Similarity NPD447 Suspended
0.6727 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6725 Remote Similarity NPD5033 Approved
0.6715 Remote Similarity NPD9265 Clinical (unspecified phase)
0.6713 Remote Similarity NPD7610 Discontinued
0.6709 Remote Similarity NPD4628 Phase 3
0.6709 Remote Similarity NPD3400 Discontinued
0.6707 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6692 Remote Similarity NPD3020 Approved
0.6691 Remote Similarity NPD4141 Clinical (unspecified phase)
0.669 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6689 Remote Similarity NPD6696 Suspended
0.6687 Remote Similarity NPD2296 Approved
0.6687 Remote Similarity NPD5616 Clinical (unspecified phase)
0.6686 Remote Similarity NPD3751 Discontinued
0.6667 Remote Similarity NPD9717 Approved
0.6667 Remote Similarity NPD3091 Approved
0.6667 Remote Similarity NPD9261 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data